Victory Capital Management
ACET icon

Victory Capital Management’s Adicet Bio ACET Stock Holding History

Victory Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,217
Closed -$504K – 2587
2022
Q3 		$504K Buy
2,217
+773
+54% +$196K ﹤0.01% 2051
2022
Q2 		$337K Buy
+1,444
New +$317K ﹤0.01% 2201
2020
Q2 		– Sell
-31
Closed -$4K – 2503
2020
Q1 		$4K Buy
+31
New +$4.6K ﹤0.01% 3326
2019
Q4 		– Sell
-25
Closed -$25K – 2629
2019
Q3 		$25K Buy
+25
New +$27.9K ﹤0.01% 2959

Other funds holding ACET

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Cowen and Company
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Victory Capital Management's ACET Position: Q4 2022 in Review

Victory Capital Management sold out of Adicet Bio (ACET) in Q4 2022, closing a stake of 2,217 shares — an estimated $504K sold.

Victory Capital Management first reported a position in ACET in Q3 2019 and held it in 4 quarters. The position peaked at $504K in Q3 2022. 99 funds tracked by Wall St. Rank hold ACET as of Q4 2022.

  • Victory Capital Management reported no remaining Adicet Bio position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 2,217 Adicet Bio shares in Q4 2022, an estimated $504K.
  • Victory Capital Management first reported a position in Adicet Bio in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's Adicet Bio position peaked at $504K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.